Intervention Review

A combination drug of abacavir-lamivudine-zidovudine (Trizivir®) for treating HIV infection and AIDS

  1. Muki Shey1,*,
  2. Eugene J Kongnyuy2,
  3. Judith Shang3,
  4. Charles Shey Wiysonge1

Editorial Group: Cochrane HIV/AIDS Group

Published Online: 8 JUL 2009

Assessed as up-to-date: 9 MAY 2009

DOI: 10.1002/14651858.CD005481.pub2

Database Title

Additional Information

How to Cite

Shey M, Kongnyuy EJ, Shang J, Wiysonge CS. A combination drug of abacavir-lamivudine-zidovudine (Trizivir®) for treating HIV infection and AIDS. Cochrane Database of Systematic Reviews 2009, Issue 3. Art. No.: CD005481. DOI: 10.1002/14651858.CD005481.pub2.

Author Information

  1. 1

    University of Cape Town, Institute of Infectious Disease and Molecular Medicine (IIDMM), Cape Town, South Africa

  2. 2

    Liverpool School of Tropical Medicine, Child and Reproductive Health Group, Liverpool, UK

  3. 3

    University of Yaounde, Yaounde, Cameroon

*Muki Shey, Institute of Infectious Disease and Molecular Medicine (IIDMM), University of Cape Town, Anzio Road, Observatory, Cape Town, 7925, South Africa. shehushey@yahoo.fr.

Publication History

  1. Publication Status: New
  2. Published Online: 8 JUL 2009

SEARCH

ARTICLE TOOLS

View Full Article (HTML) Summary (61K)Standard (214K)Full (241K)

  1. Current Version

    A combination drug of abacavir-lamivudine-zidovudine (Trizivir®) for treating HIV infection and AIDS

    Muki Shey, Eugene J Kongnyuy, Judith Shang and Charles Shey Wiysonge

    Article first published online: 8 JUL 2009 | DOI: 10.1002/14651858.CD005481.pub2

Previous versions of this article and their online publication dates

  1. Version 1

    A combination drug of abacavir-lamivudine-zidovudine (Trizivir®) for treating HIV infection and AIDS

    Muki Shey, Eugene J Kongnyuy, Judith Shang and Charles Shey U. Wiysonge

    Article first published online: 15 APR 2009 | DOI: 10.1002/14651858.CD005481

View Full Article (HTML) Summary (61K)Standard (214K)Full (241K)